Prostate cancer
EvoPAR-Prostate02
A Randomized Phase 3 double-blind, placebo-controlled, trial of saruparib vs placebo for BRCAm localized high-risk prostate cancer receiving SoC primary or salvage RT + ADT.
Trial overview
Clinical Area
Medical Oncology
Disease
Prostate
Disease site
Genitourinary (GU)
Study Phase
Phase III
Trial Identifiers
Registration number: NCT06952803
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries